Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
What Is DeSci? Decentralized Science Explained
DeSci uses blockchain, DAOs, and IP-NFTs to open up scientific funding — but the hype hid real risk for early token buyers.
DeSci — short for decentralized science — is a movement that uses blockchain, DAOs, and tokens to change how research gets funded, reviewed, and owned. No journal publisher or grant committee approves each step.
That single sentence is the whole idea. The execution is where things get interesting — and, in some cases, where they fell apart.
Traditional science runs on two choke points: who controls the money and who controls the publishing. Government agencies and private foundations decide which research gets funded. Academic journals decide what gets published and who can see it. DeSci wants to replace both with open, on-chain systems. Anyone with a governance token can vote on funding. Researchers can mint their intellectual property as an NFT. Results get published in a form anyone can access. The promise is a research pipeline owned by communities, not institutions.
Key takeaways
- DeSci replaces grant committees and journal publishers with DAOs, smart contracts, and IP-NFTs so that research funding and publishing can happen on-chain.
- Some DeSci projects — VitaDAO, BIO Protocol, ResearchHub — have deployed real money into real research. Many others raised large token rounds and produced little.
- Governance tokens let you vote on funding decisions. IP tokens represent fractional ownership of a discovery. Speculative narrative tokens represent hype. These are not the same thing.
—
What Decentralized Science (DeSci) Is Trying to Fix
Science has a funding problem. And a publishing problem. And a data-ownership problem. DeSci was built to address all three.
Start with funding. In most countries, most public research money flows through a few big agencies. The NIH in the US, Wellcome Trust in the UK, the ERC in Europe. Grant committees tend to reward safe, incremental work over high-risk ideas. Say a scientist thinks she has found a longevity compound. She faces a multi-year application and long odds of approval. And the grant terms hand her IP to the university, not to her.
Publishing compounds the problem. Most peer-reviewed journals sit behind paywalls that charge $30 to $50 per article. The scientists doing the work are rarely paid. The peer reviewers almost never are. Journals then collect subscription fees from universities that have no real alternative. So the research ends up locked away, reachable mainly by those at well-funded institutions.
The data-ownership layer is quieter but just as damaging. When a dataset or compound turns out to be valuable, the rights usually belong to the university. Not to the person who made the discovery. A scientist has no clean way to monetise her own work or share IP across labs. Community capital is off the table too, unless she goes through a VC who wants full IP in return.
The table below captures how these three problems compare across traditional and DeSci models.
| Traditional science | DeSci alternative |
|---|---|
| Funding from government agencies, private foundations, or VCs | DAO token holders vote on funding on-chain |
| Research locked behind journal paywalls ($30–$50 per article) | Results published openly on-chain, freely accessible |
| IP rights held by the university or VC funder | IP-NFT minted to researcher or DAO community |
| Peer reviewers work as unpaid volunteers | Reviewers earn tokenised rewards (e.g. ResearchCoin) |
| Grant cycles run 1–3 years from application to approval | Smart contract releases funding on milestone completion |
These are structural problems that have existed for decades. DeSci does not solve all of them cleanly — but it gives researchers new tools to work around the choke points, and that is what has driven genuine adoption.
—
How Decentralized Science (DeSci) Works — The Core Tools
DeSci runs on four building blocks. None of them require a PhD in blockchain, but each one maps directly to a specific research problem.
The first block is the DAO — a Decentralised Autonomous Organisation. In a research DAO, token holders vote on which projects to fund. The token is a governance instrument: hold it and you have a say in where the money goes. When a researcher submits a proposal, the DAO community reviews it and votes. If the vote passes, funds release. This replaces the grant committee with a community of stakeholders who have financial skin in the game.
Smart contracts are the second block. They automate what a DAO votes to do. Instead of handing a researcher a lump sum on faith, a contract can release funds in stages. 20% on launch, another 30% at a checkpoint, the rest on completion. Miss a milestone and the funds can be returned. For a researcher, that beats a grant that gets clawed back for political reasons. For a DAO, it builds accountability without a bureaucratic oversight layer.
The third block is the IP-NFT — an Intellectual Property NFT. Molecule Protocol pioneered it. When a project produces a discovery — a compound, a dataset, a patent claim — that IP is minted as an NFT. The result is a blockchain record of ownership. Fractions of that NFT can be sold or held by the DAO community. So token holders earn a share of any commercial royalties. That flips the old model. Instead of a VC buying IP in exchange for funding, a community funds the work and collectively holds the upside.
Open-access publishing rails are the fourth block. Projects like DeSci Labs let researchers assign a dPID to their datasets and papers. A dPID is a decentralised Persistent Identifier. Once on-chain, that research stays permanently accessible and reproducible, and cannot be pulled behind a paywall. For scientific integrity, that is a real improvement: a paper with on-chain data can be verified rather than just cited.
Here is how a typical DeSci project moves from idea to output. A researcher submits a proposal to a DAO. Token holders vote on funding. A smart contract releases milestone-based funds. The research gets done. An IP-NFT is minted for the discovery. Results publish on-chain under open access. Then token holders earn royalties or governance rights over that IP.
Each step in that chain has a parallel in traditional science. But in DeSci, each one happens on a public ledger. The decisions, payments, and ownership records stay visible to anyone.
—
Real Decentralized Science (DeSci) Projects Worth Knowing About
Abstractions only get you so far. Here are the DeSci projects that have shipped real work — and what they actually do.
VitaDAO is the longest-running and most-cited research DAO that has actually deployed capital. It focuses on longevity science. As of 2025, it has funded more than 24 research projects and deployed over $4.2M into early-stage longevity work. Its IP-NFT model means token holders share in the returns when a funded compound produces commercial value. Picture a community of scientists and token holders making funding calls together, rather than a hedge fund.
BIO Protocol runs as a DAO-of-DAOs. It sits above individual BioDAOs and moves capital across them. Binance Labs backed the project. In 2025, it released OX2R-004, an AI-generated peptide built by its research community and AI tools. That made BIO Protocol one of the first DeSci projects to ship a concrete AI-assisted result, not just a roadmap.
Molecule Protocol built the IP-NFT framework that most other DeSci projects now use. Its focus is biotech, helping researchers wrap drug discovery work in a tokenisable structure. The token issuance mechanics it pioneered let IP rights be fractionalised and sold to DAO communities. That model has since spread across the DeSci space.
ResearchHub takes a different approach. Rather than fund original research, it tokenises peer review. Researchers earn ResearchCoin (RSC) for submitting papers, writing summaries, and reviewing others. The goal is to pay for the unglamorous but critical work of reviewing science. In the traditional system, that work is done by unpaid volunteers.
OriginTrail focuses on data provenance — tracking where research data came from, how it was handled, and whether it can be trusted. For supply chains in pharma and biotech, data integrity is the entire point. OriginTrail’s TRAC token is not a funding mechanism but an infrastructure layer for research data integrity.
AthenaDAO focuses on women’s health research, an area historically underfunded in traditional grant systems. It uses DAO governance to fund longevity and reproductive health research, applying the same IP-NFT model as VitaDAO.
The table below summarises the six projects and their primary outputs.
| Project | What it funds / main output |
|---|---|
| VitaDAO | Longevity research — 24+ projects, $4.2M+ deployed |
| BIO Protocol | Cross-DAO coordination — AI peptide OX2R-004 (2025) |
| Molecule Protocol | Biotech IP-NFT infrastructure and drug discovery funding |
| ResearchHub | Tokenised peer review via ResearchCoin (RSC) |
| OriginTrail (TRAC) | Research data provenance for pharma supply chains |
| AthenaDAO | Women’s health and longevity research funding |
These are examples, not endorsements. Plenty of smaller BioDAOs raised large token rounds and never deployed meaningful funding. The six above stand out for one reason: they show on-chain proof of deployed capital or published research. That is the bar worth holding every DeSci project to.
—
Where Decentralized Science (DeSci) Has Failed — and What the Second Wave Is Fixing
Most DeSci explainers skip this part. They shouldn’t.
The first wave of DeSci — roughly 2021 to 2023 — was full of genuinely interesting ideas and genuinely bad execution. Three specific failures shaped the entire category.
The first was token valuation disconnect. DeSci token market caps peaked above $1 billion during the 2021-2022 cycle. Actual research funding deployed across all BioDAOs over the same period sat in the low millions. That gap was not ambition. It was speculation. Prices tracked narrative momentum, not any verifiable output.
The second failure was DAO governance concentration. A Fabric Ventures analysis of DeSci governance found that nearly 40% of active DAOs had one wallet holding a majority of voting power. So “decentralised governance” was mostly a fiction. One whale decided every vote.
The third failure was the marketing DAO. Several BioDAOs launched with slick token economics, active Discord communities, and zero peer-reviewed output. They raised capital on the promise of funding research. Then they pivoted to token marketing and never deployed. Their tokens fell 90% or more once the narrative cycle ended.
These are not edge cases — they were common enough to make the category look like a dressed-up ICO market.
Here is how to spot a token-marketing DAO versus a genuine research DAO:
- Red flag: Token market cap far exceeds any disclosed research budget.
- Red flag: No on-chain transactions showing capital deployed to researchers.
- Red flag: DAO governance has one or two wallets holding majority voting power.
- Red flag: Roadmap consists of “partnerships” and vague growth promises rather than funded research milestones.
- Green flag: On-chain treasury transactions link to identifiable research grants.
- Green flag: Published outputs (papers, compounds, datasets) with verifiable authorship.
- Green flag: Milestone-based smart contract releases rather than lump-sum DAO treasury grants.
The second wave, from 2024 onward, is smaller and more honest about what governance really takes. BIO Protocol’s aggregator-of-DAOs structure spreads power across many DAOs before pooling it at the protocol level, which cuts capture risk. dPIDs give research data a permanent identifier that cannot be tampered with later. And milestone-based smart contracts swap speculative payouts for verifiable progress gates.
The AI angle is also real, not just a talking point. BIO Protocol’s OX2R-004 peptide was built with AI-assisted research tools and the DAO community. That is the AI plus DeSci combination producing an actual output, not a whitepaper promise.
Early DeSci was half promise, half speculation. The second generation is smaller, more focused, and producing actual outputs. That does not make every current project legitimate, but it does mean the category has moved past the pure narrative phase.
—
Decentralized Science (DeSci) Tokens and How the Crypto Side Works
Not all DeSci tokens are the same. Calling them all “DeSci crypto” obscures four very different things.
Governance tokens give you voting rights in a DAO. VITA (VitaDAO) and BIO (BIO Protocol) are the two clearest examples. Hold either and you can vote on funding, governance changes, and treasury moves. Their value tracks the perceived quality of the DAO’s research pipeline. It does not track any single discovery.
IP tokens represent fractional ownership of a specific IP-NFT. When a research project mints its intellectual property as an NFT, that NFT can be fractionalised and sold to the community. Holding an IP token means you own a piece of that specific discovery — and you earn a share of any royalties if the IP is licensed commercially.
Reward tokens are earned rather than bought. ResearchCoin (RSC) is the clearest example: researchers earn it for submitting papers, writing peer reviews, and contributing to the ResearchHub platform. It has a functional use within the platform and can be traded on exchanges.
Speculative narrative tokens are the fourth category — and the most dangerous. These are tokens associated with DeSci branding but with no clear governance utility, no IP ownership, and no reward mechanism. They trade purely on narrative momentum. They are the tokens that collapsed 90%+ after the first DeSci hype cycle ended.
Some DeSci DAOs issue tokens through bonding curves. Price rises automatically as more supply gets bought from the curve contract. That rewards early buyers and keeps a liquid market. Knowing this helps you tell real demand from pure curve mechanics, so you do not read a rising chart as a signal.
| Token type | What it represents |
|---|---|
| Governance token (e.g., VITA, BIO) | Voting rights over DAO funding and treasury decisions |
| IP token | Fractional ownership of a specific IP-NFT and its royalty stream |
| Reward token (e.g., RSC) | Earned for contributing peer review, papers, or data |
| Narrative token | Priced on hype — no verifiable utility or research backing |
The CoinGecko DeSci category showed a combined market cap of roughly $352 million as of mid-2026. That sits well below the $1 billion-plus peak of the 2021-2022 cycle. The drop reflects the market correction and the exit of the purely speculative projects. What is left is concentrated in a few tokens with genuine on-chain activity.
DeSci governance tokens earn you a say, but rarely a direct yield from holding. If you want to see how on-chain positions can pay a recurring reward instead, liquid staking tokens are a cleaner example of that model. The contrast helps you judge what a DeSci token actually pays you for.
The regulatory status of DeSci tokens is unclear in most jurisdictions as of mid-2026. Governance tokens may or may not count as securities. It depends on how courts read voting rights and any expectation of profit. IP tokens that pay royalties are more likely to draw securities scrutiny. Nothing here is financial or legal advice.
—
How to Get Involved in Decentralized Science (DeSci)
Getting into DeSci does not require buying tokens. It depends on what you are trying to do.
For Researchers and Scientists
The most direct entry points are:
- Submit your work to ResearchHub for tokenised peer review and access to the RSC rewards system.
- Apply for a VitaDAO or BIO Protocol research grant through their public grant portals — both accept proposals in longevity and biotech respectively.
- Publish datasets on-chain using DeSci Labs tools, which assign a dPID to your data and make it permanently accessible.
- Explore Molecule Protocol if your work involves drug discovery or patentable biotech research.
For Token Holders and Governance Voters
Voting in a DeSci DAO is easier than most people expect. Buy VITA or BIO on a centralised exchange or DEX. Then connect your wallet to that DAO’s governance portal. Read the active proposals first. Most forums are public and open without holding a single token. Then vote on the funding decisions that interest you. Even a small position carries real weight here. Turnout is low, so engaged smaller holders punch above their size.
For the Curious Non-Investor
You do not need a wallet, a token, or a plan to start learning. Open research on ResearchHub is free to browse with no account. VitaDAO and BIO Protocol both run public Discord channels where researchers and token holders argue over live proposals. And DeSci Labs is worth a follow for practitioner-level updates on what the decentralized science community is actually shipping. That is enough to judge whether the space fits you before any money moves.
Governance is the most underused entry point of the three. Turnout is low across most DeSci DAOs, so a modest token position can still shape where research funding goes. A few DAOs are also testing non-token routes, letting researchers or domain experts weigh in on proposals without owning tokens at all.
—
Where To Start With DeSci This Week
The easiest first move depends on your angle.
If you are a researcher, submit one paper or dataset to ResearchHub this week. The RSC rewards are real, and reading how proposals get voted up or down will teach you more about DeSci governance than any explainer.
If you want token exposure, check the on-chain treasury activity of VITA or BIO before buying. Both projects publish their grant transactions publicly. If you cannot find deployed capital on-chain, do not buy the token on a narrative alone.
If you are just curious, start with VitaDAO’s public forum. Every funded project has a proposal thread you can read without a wallet. That is the fastest way to see whether a research DAO is actually doing science or just running a Discord.
One thing to avoid: buying a DeSci token because of a price chart. The first wave of DeSci showed exactly what happens when speculation runs ahead of research output. Check the outputs first.
—
FAQ
What is decentralized science (DeSci)?
DeSci stands for Decentralised Science. It is a movement that uses blockchain, DAOs, and tokens to change how research gets funded, reviewed, and shared. No journal publisher or grant committee controls each step. Researchers can raise capital from DAO communities, publish data on-chain, and tokenise their intellectual property instead of signing it away to institutions.
What is an IP-NFT in decentralized science (DeSci)?
An IP-NFT is a blockchain token that represents ownership of a piece of intellectual property. That could be a research compound, a dataset, or a patent claim. Minting one creates an on-chain record of who owns it. That record can be fractionalised, so a DAO community can hold a discovery together instead of signing full rights to a VC or university. If the IP earns royalties, those flow to IP-NFT holders. This is what makes DeSci economically different from plain open-access publishing.
Is decentralized science (DeSci) worth investing in?
Some DeSci projects — VitaDAO, BIO Protocol, ResearchHub — have funded real research and shipped real outputs. Governance tokens in these projects carry actual voting rights, so their utility goes beyond speculation. Other DeSci tokens are narrative plays that collapsed 90% or more when the hype faded. The difference is verifiable on-chain. Check whether the DAO has publicly deployed research funding and published outputs, not just raised capital. This is not financial advice, and the regulatory status of DeSci tokens is still unclear in most jurisdictions.
How does decentralized science (DeSci) compare to open science?
Open science is a publishing philosophy: make papers freely available so anyone can read them. DeSci uses blockchain to go further. It tokenises ownership of research IP, automates funding through smart contracts, and makes governance transparent on-chain. Open science predates DeSci by decades and involves no tokens or DAOs. DeSci layers a crypto-native incentive on top of open-access principles. So it creates financial stakes that open science never had.
Which decentralized science (DeSci) projects are actually doing real research?
Three projects have the strongest on-chain record of deployed research funding. VitaDAO has funded 24+ projects and deployed over $4.2M in longevity research. BIO Protocol released the AI-generated peptide OX2R-004 in 2025. ResearchHub runs an active peer-review reward system. Many other BioDAOs raised large rounds and deployed little or no capital. The fastest check is on-chain: look at treasury transactions, not marketing announcements.
—
